Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Is the UK Creating a Fairer Path for New MedTech?
Tech & Innovation Is the UK Creating a Fairer Path for New MedTech?

The United Kingdom's healthcare landscape has long presented a paradox for medical technology innovators, where groundbreaking devices and diagnostics capable of transforming patient outcomes often face a fragmented and unpredictable journey to widespread adoption within the National Health Service

Can US Biomedical Research Recover From a Year of Chaos?
Clinical & Pharma Can US Biomedical Research Recover From a Year of Chaos?

The American biomedical research landscape has emerged into 2026 bearing the deep and complex scars of a profoundly turbulent year, navigating a delicate balance between a renewed sense of financial security and a pervasive anxiety over the integrity of its foundational institutions. Following a

Closing the Diversity Gap in Parkinson's Research
Clinical & Pharma Closing the Diversity Gap in Parkinson's Research

The global map of Parkinson's disease is rapidly being redrawn, yet the landscape of the research dedicated to conquering it remains stubbornly fixed. A profound and widening disparity now exists between the populations most affected by this neurodegenerative condition and the focus of scientific

Healthcare's Digital Future Hinges on the Basics
Tech & Innovation Healthcare's Digital Future Hinges on the Basics

As an expert in robotics and IoT applications in medicine, James Maitland has dedicated his career to a powerful, singular passion: leveraging technology to advance healthcare solutions. Yet, he cautions that the industry's rush toward futuristic concepts like AI and virtual hospitals often

Can Vynca's New CMO Redefine Serious Illness Care?
Management & Administration Can Vynca's New CMO Redefine Serious Illness Care?

The landscape of serious illness care in the United States is fraught with challenges, leaving millions of vulnerable patients and their families navigating a fragmented and often reactive healthcare system. In this high-stakes environment, health technology company Vynca has made a definitive move

HHS Drops 340B Rebate Pilot After Hospital Lawsuit
Management & Administration HHS Drops 340B Rebate Pilot After Hospital Lawsuit

A contentious federal pilot program designed to overhaul how safety-net hospitals are compensated for prescription drugs has been abruptly withdrawn by the Department of Health and Human Services (HHS) following a decisive legal challenge. The proposed 340B Rebate Model Pilot, which was set to

What Does the FDA's Steady Pace Mean for Medtech?
Tech & Innovation What Does the FDA's Steady Pace Mean for Medtech?

After years of meteoric growth that redefined the landscape for innovative medical technology, the U.S. Food and Drug Administration's (FDA) Breakthrough Devices Program has settled into a new, more predictable rhythm. This shift from rapid acceleration to a consistent, high-volume cadence signals

A New Way to Treat BPH Without Drugs or Surgery?
Tech & Innovation A New Way to Treat BPH Without Drugs or Surgery?

For millions of aging men, the diagnosis of Benign Prostatic Hyperplasia, or an enlarged prostate, presents an unwelcome crossroads between enduring disruptive urinary symptoms and accepting treatments with significant drawbacks. This condition affects an estimated 50% of men between 51 and 60, a

How a Cave Experiment Revealed Our Biological Clock
Clinical & Pharma How a Cave Experiment Revealed Our Biological Clock

The intricate rhythm of day and night has governed life on Earth for eons, yet one French scientist’s daring descent into the planet’s depths revealed that a far more personal timepiece ticks within us all. In 1962, Michel Siffre embarked on a journey of self-experimentation that fundamentally

Medicare ACO Program Hits Record Growth and Savings
Management & Administration Medicare ACO Program Hits Record Growth and Savings

A strategic shift in healthcare delivery is gaining unprecedented momentum, with a record-breaking 14.3 million seniors now receiving care through Medicare's coordinated networks, marking a significant 4.4% increase from the previous year. This expansion is not merely about numbers; it represents a

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later